Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study

Rationale: Bedaquiline and delamanid offer the possibility of more effective and less toxic treatment for multidrug-resistant (MDR) tuberculosis (TB). With this treatment, however, some patients remain at high risk for an unfavorable treatment outcome. The endTB Observational Study is the largest mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Franke, Molly F., Khan, Palwasha, Hewison, Cathy, Khan, Uzma, Huerga, Helena, Seung, Kwonjune J., Rich, Michael L., Zarli, Khin, Samieva, Nazgul, Oyewusi, Lawrence, Nair, Parvati, Mudassar, Mishaz, Melikyan, Nara, Lenggogeni, Putri, Lecca, Leonid, Kumsa, Andargachew, Khan, Munira, Islam, Shirajul, Hussein, Kerow, Docteur, Wisny, Chumburidze, Nino, Berikova, Elmira, Atshemyan, Hakob, Atwood, Sidney, Alam, Manzurul, Ahmed, Saman, Bastard, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781121/
https://www.ncbi.nlm.nih.gov/pubmed/32706644
http://dx.doi.org/10.1164/rccm.202001-0135OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781121/
https://www.ncbi.nlm.nih.gov/pubmed/32706644
http://dx.doi.org/10.1164/rccm.202001-0135OC

Ejemplares similares